Insider · CIK 0001786391

Hindson Benjamin J.

Reports to the SEC for 1 company · PLEASANTON, CA

sec.gov

Transactions

Companies

Filings

CIK

0001786391

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-08-24	TXG10x Genomics, Inc.S Sale	Director, See Remarks	SSale	−13.8K sh	$63.02	−$871K	488,182
2026-05-22	TXG10x Genomics, Inc.S Sale	Director, See Remarks	SSale	−11.6K sh	$24.44	−$283K	502,000
2026-02-26	TXG10x Genomics, Inc.A Award	Director, See Remarks	AAward	+88.8K sh	—	—	513,595
2026-02-23	TXG10x Genomics, Inc.S Sale	Director, See Remarks	SSale	−7,826 sh	$18.58	−$145K	424,779
2025-11-24	TXG10x Genomics, Inc.S Sale	Director, See Remarks	SSale	−8,283 sh	$19.00	−$157K	432,605
2025-08-22	TXG10x Genomics, Inc.S Sale	Director, See Remarks	SSale	−7,486 sh	$13.79	−$103K	440,888
2025-05-22	TXG10x Genomics, Inc.S Sale	Director, See Remarks	SSale	−7,485 sh	$8.30	−$62.1K	448,374
2025-03-17	TXG10x Genomics, Inc.A Award	Director, See Remarks	AAward	+121K sh	—	—	455,859
2025-02-24	TXG10x Genomics, Inc.S Sale	Director, See Remarks	SSale	−4,573 sh	$11.07	−$50.6K	335,324
2024-11-22	TXG10x Genomics, Inc.S Sale	Director, See Remarks	SSale	−5,807 sh	$13.69	−$79.5K	339,897
2024-08-22	TXG10x Genomics, Inc.S Sale	Director, See Remarks	SSale	−4,351 sh	$22.53	−$98K	345,704
2024-05-22	TXG10x Genomics, Inc.S Sale	Director, See Remarks	SSale	−4,087 sh	$24.30	−$99.3K	350,055
2024-03-21	TXG10x Genomics, Inc.A Award	Director, See Remarks	AAward	+71.1K sh	—	—	354,142
2024-02-22	TXG10x Genomics, Inc.S Sale	Director, See Remarks	SSale	−2,613 sh	$46.34	−$121K	283,059
2023-12-28	TXG10x Genomics, Inc.M Exercise/Conversion	Director, See Remarks	MExercise/Conversion	+8,334 sh	$11.48	+$95.7K	285,672
2023-12-28	TXG10x Genomics, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director, See Remarks	MExercise/Conversion	−8,334 sh	—	—	14,978
2023-11-22	TXG10x Genomics, Inc.S Sale	Director, See Remarks	SSale	−3,449 sh	$43.34	−$149K	277,338
2023-08-22	TXG10x Genomics, Inc.S Sale	Director, See Remarks	SSale	−3,449 sh	$45.78	−$158K	280,787
2023-08-01	TXG10x Genomics, Inc.M Exercise/Conversion	Director, See Remarks	MExercise/Conversion	+6,970 sh	$11.48	+$80K	291,206
2023-08-01	TXG10x Genomics, Inc.S Sale	Director, See Remarks	SSale	−1,727 sh	$61.77	−$107K	289,479
2023-08-01	TXG10x Genomics, Inc.S Sale	Director, See Remarks	SSale	−5,243 sh	$62.36	−$327K	284,236
2023-08-01	TXG10x Genomics, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director, See Remarks	MExercise/Conversion	−6,970 sh	—	—	23,312
2023-07-19	TXG10x Genomics, Inc.M Exercise/Conversion	Director, See Remarks	MExercise/Conversion	+13K sh	$5.04	+$65.4K	297,208
2023-07-19	TXG10x Genomics, Inc.M Exercise/Conversion	Director, See Remarks	MExercise/Conversion	+968 sh	$11.48	+$11.1K	298,176
2023-07-19	TXG10x Genomics, Inc.S Sale	Director, See Remarks	SSale	−13.9K sh	$60.03	−$837K	284,236
2023-07-19	TXG10x Genomics, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director, See Remarks	MExercise/Conversion	−13K sh	—	—	0
2023-07-19	TXG10x Genomics, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director, See Remarks	MExercise/Conversion	−968 sh	—	—	30,282
2023-05-23	TXG10x Genomics, Inc.S Sale	Director, See Remarks	SSale	−243 sh	$55.06	−$13.4K	286,381
2023-05-23	TXG10x Genomics, Inc.S Sale	Director, See Remarks	SSale	−619 sh	$55.06	−$34.1K	285,762
2023-05-23	TXG10x Genomics, Inc.S Sale	Director, See Remarks	SSale	−735 sh	$55.06	−$40.5K	285,027
2023-05-23	TXG10x Genomics, Inc.S Sale	Director, See Remarks	SSale	−791 sh	$55.06	−$43.6K	284,236
2023-03-21	TXG10x Genomics, Inc.A Award	Director, See Remarks	AAward	+36.4K sh	—	—	286,624
2023-03-21	TXG10x Genomics, Inc. · Stock Option (right to buy)A Award	Director, See Remarks	AAward	+36.4K sh	—	—	36,387
2023-03-21	TXG10x Genomics, Inc. · Performance- based Restricted Stock UnitsA Award	Director, See Remarks	AAward	+18.2K sh	—	—	18,194
2023-02-22	TXG10x Genomics, Inc.S Sale	Director, See Remarks	SSale	−1,742 sh	$47.75	−$83.2K	250,237
2022-12-14	TXG10x Genomics, Inc.M Exercise/Conversion	Director, See Remarks	MExercise/Conversion	+34.3K sh	$5.04	+$173K	251,979
2022-12-14	TXG10x Genomics, Inc. · Stock Option (right to buy)M Exercise/Conversion	Director, See Remarks	MExercise/Conversion	−34.3K sh	—	—	12,972
2022-11-22	TXG10x Genomics, Inc.S Sale	Director, See Remarks	SSale	−359 sh	$34.07	−$12.2K	219,715
2022-11-22	TXG10x Genomics, Inc.S Sale	Director, See Remarks	SSale	−915 sh	$34.07	−$31.2K	218,800
2022-11-22	TXG10x Genomics, Inc.S Sale	Director, See Remarks	SSale	−1,087 sh	$34.07	−$37K	217,713
2022-09-14	TXG10x Genomics, Inc.A Award	Director, See Remarks	AAward	+33.8K sh	—	—	220,074
2022-09-14	TXG10x Genomics, Inc. · Stock Option (right to buy)A Award	Director, See Remarks	AAward	+67.7K sh	—	—	67,655
2022-09-14	TXG10x Genomics, Inc. · Performance-based Restricted Stock UnitsA Award	Director, See Remarks	AAward	+67.7K sh	—	—	67,655
2022-08-23	TXG10x Genomics, Inc.S Sale	Director, See Remarks	SSale	−1,292 sh	$35.19	−$45.5K	186,246
2022-05-23	TXG10x Genomics, Inc.S Sale	Director, See Remarks	SSale	−1,264 sh	$48.76	−$61.6K	187,538
2022-03-22	TXG10x Genomics, Inc.A Award	Director, See Remarks	AAward	+28.5K sh	—	—	188,802
2022-03-22	TXG10x Genomics, Inc. · Stock Option (Right to Buy)A Award	Director, See Remarks	AAward	+71.2K sh	—	—	71,189
2022-02-22	TXG10x Genomics, Inc.S Sale	Director, See Remarks	SSale	−360 sh	$78.59	−$28.3K	160,326
2022-02-22	TXG10x Genomics, Inc. · Class B Common StockG Gift	Director, See Remarks	GGift	−267K sh	—	—	2,733,000
2022-02-22	TXG10x Genomics, Inc. · Class B Common StockG Gift	Director, See Remarks	GGift	+134K sh	—	—	133,500

Recent filings

Accepted (ET)
Aug 264
Hindson Benjamin J.0001610717-26-000390
SEC(opens sec.gov)
May 274
Hindson Benjamin J.0001610717-26-000163
SEC(opens sec.gov)
Mar 24
Hindson Benjamin J.0001610717-26-000076
SEC(opens sec.gov)
Feb 254
Hindson Benjamin J.0001610717-26-000068
SEC(opens sec.gov)
Nov 254
Hindson Benjamin J.0001610717-25-000399
SEC(opens sec.gov)
Aug 264
Hindson Benjamin J.0001610717-25-000319
SEC(opens sec.gov)
May 274
Hindson Benjamin J.0001610717-25-000143
SEC(opens sec.gov)
Mar 194
Hindson Benjamin J.0001610717-25-000074
SEC(opens sec.gov)
Feb 264
Hindson Benjamin J.0001610717-25-000037
SEC(opens sec.gov)
Nov 254
Hindson Benjamin J.0001610717-24-000529
SEC(opens sec.gov)
Aug 264
Hindson Benjamin J.0001610717-24-000454
SEC(opens sec.gov)
May 234
Hindson Benjamin J.0001610717-24-000257
SEC(opens sec.gov)
Mar 254
Hindson Benjamin J.0001610717-24-000185
SEC(opens sec.gov)
Feb 264
Hindson Benjamin J.0001610717-24-000091
SEC(opens sec.gov)
Dec 294
Hindson Benjamin J.0001610717-23-000427
SEC(opens sec.gov)
Nov 274
Hindson Benjamin J.0001610717-23-000366
SEC(opens sec.gov)
Aug 244
Hindson Benjamin J.0001610717-23-000235
SEC(opens sec.gov)
Aug 34
Hindson Benjamin J.0001610717-23-000222
SEC(opens sec.gov)

Companies

10x Genomics, Inc.Director, See RemarksTXG

Address

10X GENOMICS, INC. 6230 STONERIDGE MALL ROAD

PLEASANTON, CA, 94588